Navitas Pharma

Navitas Pharma Our lead product is in Phase II for NASH/NAFLD and cirrhosis associated with portal hypertension in

Address

New York, NY
10029

Alerts

Be the first to know and let us send you an email when Navitas Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share